SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-029231
Filing Date
2013-05-15
Accepted
2013-05-15 13:13:30
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v343763_10q.htm 10-Q 393314
2 EXHIBIT 31.1 v343763_ex31-1.htm EX-31.1 11759
3 EXHIBIT 31.2 v343763_ex31-2.htm EX-31.2 11690
4 EXHIBIT 32.1 v343763_ex32-1.htm EX-32.1 4789
5 EXHIBIT 32.2 v343763_ex32-2.htm EX-32.2 5018
6 GRAPHIC page11.jpg GRAPHIC 87837
  Complete submission text file 0001144204-13-029231.txt   2674945

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT syn-20130331.xml EX-101.INS 298582
8 XBRL TAXONOMY EXTENSION SCHEMA syn-20130331.xsd EX-101.SCH 28599
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20130331_cal.xml EX-101.CAL 27792
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20130331_def.xml EX-101.DEF 132419
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20130331_lab.xml EX-101.LAB 233843
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20130331_pre.xml EX-101.PRE 161640
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 13845347
SIC: 2834 Pharmaceutical Preparations